Draper Fisher Jurvetson lead $5 million Series A financing round in Glycos Biotechnologies; converting low-value, low-purity carbon sources drop in renewable chemicals

In Texas, Draper Fisher Jurvetson and DFJ Mercury announced that they have led and close a $5.0 million series A investment round in Glycos Biotechnologies. Glycos is using microbes and fermentation technologies as an alternative to petrochemical-based manufacturing, based on technology licensed from Rice University.

The technology is focused on converting low-value, low-purity carbon sources into high quality, non-petroleum sourced chemicals that are molecularly identical to current petrochemical-based chemicals, and upgrades glycerin-rich co-products to a variety of chemical intermediates.  The proceeds from the Series A round will be used to hire key technical talent and to commercialize GlycosBio technology to manufacturing scale.

Free Subscription to the Daily Biofuels Digest e-newsletter

Related Stories

GlycosBio: 50 Hottest Companies in Bioenergy candidate profile

Glycos Biotechnologies Based in: Texas 2008-09 ranking: Unranked Business: GlycosBio uniquely discovered a number of microorganisms that biologically make green chemical intermediates from a vari...

Amyris Technolgies closes $70 million in second-round financing to pursue new biofuel conversion technologies

In California, Amyris Biotechnologies has closed the first tranche of its $70 million Series B funding led by DAG Ventures and joined by Khosla Ventures, Kleiner Perkins Caufiled & Byers and TPG Ventu...

“Biorefinery-in-a-box” to debut in Idaho with revenue sharing model for wastewater oil recovery

In Idaho, the first "biorefinery-in-a-box" deployed by BioFuelBox to convert landfill sludge into biofuels will be installed in January. The company targets fats and oils extracted from wastewater, wh...

Novomer raises $14 million in Series B for renewable chemicals and polymers from CO2, other renewable feedstocks

In Massachusetts, Novomer announced that it has completed a Series B funding round of $14 million, led by OVP Venture Partners. The company makes low-cost plastics, polymers and other chemicals from r...

OPX Biotechnologies closes $12 million series C funding for microbe modification technology for advanced biofuels

In Colorado, Boulder, genomic search company OPX Biotechnologies is reported to have closed a $12.1 million series C financing round, the first cleantech venture capital round reported this month with...

Amyris Biotechnologies raises $41.7 million to date in Series C investment round

In California, Greentech Media is reporting that Amyris Biotechnologies has received new investment from GrupoCornelioBrennand in Brazil and Naxos in the United Kingdom,  among other investors in the...